About Us
Biotech Consortium India Limited (BCIL) is a public limited company, promoted by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and set up by All India Financial Institutions including IDBI, ICICI, IFCI, UTI and IFCI Venture Capital Funds Limited.
BCIL was incorporated under the Companies Act 1956(Now Company Act, 2013) in 1990 with government in advisory role, development banks as major funding agency.
It is a nodal agency for providing business support services to facilitate accelerated commercialization of biotech products and processes.
The company was inaugurated in 1990 by the then Prime Minister of India, Hon’ble Shri Chandra Shekhar, in presence of the Finance Minister, Shri. Yashwant Sinha and Dr. Manju Sharma, Secretary, Department of Biotechnology.
Read MoreLaunch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP)
Launch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP) of Department of Biotechnology, (DBT), Ministry of Science and Technology, Government of India, being managed by Biotech Consortium India Limited (BCIL) by Dr. Renu Swarup, Secretary, DBT on 14th June, 2018.
WHAT'S NEW
Biotech Consortium India Limited (BCIL) is delighted to announce that on 02 November 2026, BCIL has successfully transferred three promising probiotic technologies developed at the BRIC-National Agri-Food Biomanufacturing Institute (BRIC NABI), Mohali.The licensing event took place in the gracious presence of Professor Ashwani Pareek, Executive Director, BRIC-NABI, Dr. Purnima Sharma, Managing Director, BCIL, Mr. Dinesh Kumar Arora, Managing Director & CEO, and Mr. Bimal Trivedi, Executive Director, Sundyota Numandis Probioceuticals Pvt. Ltd.
Biotech Consortium India Limited (BCIL) is pleased to announce the signing of a Memorandum of Agreement (MoA) with MACS-Agharkar Research Institute (ARI) on 28 October 2026 in Pune, in the areas of innovation management and technology transfer. The MoA was executed by Dr. Prashant K. Dhakephalkar, Director, ARI and Dr. Purnima Sharma Managing Director, BCIL.
Biotech Consortium India Limited (BCIL) is delighted to announce the signing of a Memorandum of Agreement (MoA) with the Madhya Pradesh Council of Science & Technology (MPCOST) on 1st August 2026 in Bhopal, marking the beginning of a strategic partnership to strengthen the biotechnology and innovation ecosystem in Madhya Pradesh. The MoA was executed in the esteemed presence of Dr. Shekhar Mande President, Indian National Science Academy (INSA), Chairman, BCIL, and Former Secretary, DSIR & Director General, CSIR by Dr.